MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Clinical features"

  • 2025 International Congress

    Clinical validity of a digital toolkit combining active and passive assessments in early Parkinson’s Disease

    J. Lavine, J. Bakker, G. Stephenson, A. Scotina, A. Amara, M. Dockendorf, R. Ellis, S. Frank, O. Harari, S. Isaacson, O. Levy, P. Lewitt, J. Liebenthal, E. Mangin, Z. Mari, J. Morgan, O. Patil, B. Rankin, J. Ren, R. Rodriguez, S. Stoch, D. Tu, S. Upadhyay, J. Urbanek, M. Wipperman, L. Omberg, J. Wagner (New York, USA)

    Objective: We evaluated clinical validity of smartphone-administered active assessments and passive measures of motor function in early Parkinson’s Disease (PD) designed for in-home remote use.…
  • 2025 International Congress

    CAPOS Phenotypic Spectrum: CAPOS, CAPOS+ and CAPOS- within the p.Glu831Lys Variant of the ATP1A3 gene. Case Report and Literature Review.

    E. Olivas-Domínguez, R. Romero-Armenta, M. Ramírez-García, H. Martínez-Hernández (Mexico City, Mexico)

    Objective: To describe and compare the clinical phenotype and frequency of symptom presentation of p.Glu831Lys variant associated syndrome within the ATP1A3 gene, adding the first…
  • 2025 International Congress

    Alterations in Gait Initiation of subjects with Parkinson’s Disease: a comparative study with matched healthy controls

    D. Bonacina, D. Tosatto, A. Arrighetti, C. Perin, C. Alessandro, D. Piscitelli (Storrs, USA)

    Objective: To compare spatiotemporal, kinetic and kinematic variables of Gait Initiation (GI) between individuals with Parkinson’s disease (PD) and healthy controls (HC). Background: Balance and…
  • 2025 International Congress

    Gait Analysis and Outcome of CSF Drainage in Patients of Normal Pressure Hydrocephalus

    S. Patel, C. Sankhla (Mumbai, India)

    Objective: NPH is a clinical entity causing impairment in gait, bladder and memory functions. Of these, gait dysfunction is the most prominent and disabling as…
  • 2025 International Congress

    Spatiotemporal Gait Norms in Moderate-to-Advanced Parkinson’s Disease

    K. Miller, R. Tripathi, S. Solano, S. Factor, J. Mckay, C. Esper (Atlanta, USA)

    Objective: Understanding gait abnormalities in moderate-to-advanced Parkinson’s disease (PD) is essential to enhance patient mobility and optimize clinical management [1]. This study aims to establish…
  • 2025 International Congress

    Examining the Influence of Task Complexity on Dual Task Performance in Parkinson’s disease.

    S. Conklin, P. Hill, L. Schwarz, YF. Chiu, J. Longhurst (Saint Louis, USA)

    Objective: This study aimed to examine the impact of walking task complexity and cognitive speaking task (CST) condition on dual-task effects (DTE) in people with…
  • 2025 International Congress

    Analysis of Diagnostic Outcomes and Imaging Features in Patients with Ventriculomegaly and Gait Impairment

    C. Espinoza-Vinces, I. Avilés-Olmos, J. Núñez Córdoba, M. Jiménez Vázquez, M. Calvo Imirizaldu, G. Martí-Andrés, M. Luquin (Pamplona, Spain)

    Objective: To describe the clinical features, diagnostic outcomes, and brain MRI imaging characteristics in patients with ventriculomegaly and gait impairment Background: Emerging evidence suggests that ventriculomegaly,…
  • 2025 International Congress

    Relationships Between Preferred Walking Speed and Accelerations at the Head and Trunk in Individuals with Parkinson’s Disease (PD) and Healthy Elderly

    P. Prupetkaew, A. Grunsfeld, S. Morrison, D. Russell (Norfolk, USA)

    Objective: To assess the relationship between head and trunk accelerations and the preferred walking speed (PWS) in individuals with and without PD Background: Bradykinesia and…
  • 2025 International Congress

    Objective Monitoring of Axial symptoms in Parkinson’s Disease (OMNIA-PARK): the Study Protocol.

    S. Gallo, M. Patera, G. Imbalzano, A. Zampogna, M. Ghislieri, U. Mosca, G. Amprimo, L. Borzì, S. Cerfoglio, MA. Gazzanti Pugliese, GL. Cerone, A. Botter, V. Cimolin, C. Claudia, L. Lopiano, F. Irrera, G. Olmo, A. Suppa, CA. Artusi (Pozzilli

    Objective: This study aims to develop and validate a technological set up for the objective assessment and continuous monitoring of axial symptoms in Parkinson’s Disease…
  • 2025 International Congress

    Gait Variability is Associated with Executive Function in Progressive Supranuclear Palsy

    A. D'Souza, C. Sotirakis, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: This study aims to investigate the relationship between executive function and gait in PSP using clinical assessments and objective gait analysis with wearable sensors.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 46
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley